These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34248223)

  • 1. A shorter post-exposure prophylaxis regimen for rabies, Pakistan.
    Salahuddin N; Ansari N; Gohar MA
    Bull World Health Organ; 2021 Jul; 99(7):506-513. PubMed ID: 34248223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing Cost of Rabies Post Exposure Prophylaxis: Experience of a Tertiary Care Hospital in Pakistan.
    Salahuddin N; Gohar MA; Baig-Ansari N
    PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004448. PubMed ID: 26919606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economical multi-site intradermal regimen with purified chick embryo cell vaccine (Rabipur) prevents rabies in people bitten by confirmed rabid animals.
    Madhusudana SN; Anand NP; Shamsundar R
    Int J Infect Dis; 2002 Sep; 6(3):210-4. PubMed ID: 12718837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound-only injection of rabies immunoglobulin (RIG) saves lives and costs less than a dollar per patient by "pooling strategy".
    Bharti OK; Thakur B; Rao R
    Vaccine; 2019 Oct; 37 Suppl 1():A128-A131. PubMed ID: 31395454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal rabies post-exposure prophylaxis can be abridged with no measurable impact on clinical outcome in Cambodia, 2003-2014.
    Tarantola A; Ly S; Chan M; In S; Peng Y; Hing C; Taing CN; Phoen C; Ly S; Cauchemez S; Buchy P; Dussart P; Bourhy H; Mary JY
    Vaccine; 2019 Oct; 37 Suppl 1():A118-A127. PubMed ID: 30454946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study.
    WHO Rabies Modelling Consortium
    Lancet Infect Dis; 2019 Jan; 19(1):102-111. PubMed ID: 30472178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study.
    Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A
    Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in human rabies prophylaxis.
    Warrell MJ
    Rev Sci Tech; 2018 Aug; 37(2):629-647. PubMed ID: 30747121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabies post-exposure vaccination in 2 visits within a week: A 4-site intradermal regimen.
    Warrell MJ
    Vaccine; 2019 Feb; 37(9):1131-1136. PubMed ID: 30691982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.
    Krzowska-Firych J; Tomasiewicz K; Kozøowska A
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28166482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure.
    Warrell MJ
    Travel Med Infect Dis; 2012 Jan; 10(1):1-15. PubMed ID: 22342356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
    Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G
    Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of health seeking behaviour following rabies exposure in Ethiopia.
    Beyene TJ; Mourits MCM; Revie CW; Hogeveen H
    Zoonoses Public Health; 2018 Jun; 65(4):443-453. PubMed ID: 29524317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of rabies post exposure prophylaxis in Iran.
    Hatam N; Esmaelzade F; Mirahmadizadeh A; Keshavarz K; Rajabi A; Afsar Kazerooni P; Ataollahi M
    J Res Health Sci; 2014; 14(2):122-7. PubMed ID: 24728746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of operating Animal Bite Treatment Centers in the Philippines from a health provider perspective.
    Amparo ACB; Jayme SI; Roces MCR; Quizon MCL; Villalon EES; Quiambao BP; Baquilod MS; Hernandez LM; Taylor LH; Nel LH
    PLoS One; 2018; 13(7):e0199186. PubMed ID: 30001378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first report evaluating the post-exposure rabies prophylaxis in children exposed to animals in the Lublin Province (Eastern Poland) in 2010-2016 - a retrospective study.
    Krzowska-Firych J; Mazurek E; Hasiec B; Tomasiewicz K
    Hum Vaccin Immunother; 2018; 14(11):2660-2665. PubMed ID: 29771638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania.
    Shim E; Hampson K; Cleaveland S; Galvani AP
    Vaccine; 2009 Nov; 27(51):7167-72. PubMed ID: 19925948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1 ml PCEC rabies vaccine administered intradermally using the Thai Red Cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals.
    Quiambao BP; Dimaano EM; Ambas C; Davis R; Banzhoff A; Malerczyk C
    Vaccine; 2005 Feb; 23(14):1709-14. PubMed ID: 15705476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis.
    Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M
    Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modelling to inform prophylaxis regimens to prevent human rabies.
    Hampson K; Abela-Ridder B; Bharti O; Knopf L; Léchenne M; Mindekem R; Tarantola A; Zinsstag J; Trotter C
    Vaccine; 2019 Oct; 37 Suppl 1(Suppl 1):A166-A173. PubMed ID: 30528846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.